An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance Medication
NCT00577265 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2011-01-28
Summary
An observational study to investigate how patients experience the ability to adjust their asthma maintenance medication according to instructions received from their physician. The primary aim is to create an insight in the perception of the patient when he has the ability to adjust his own maintenance treatment and how the patient exercises this in the daily practice.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Hannie de Munnik · AstraZeneca
-
Monique Scholtes · AstraZeneca
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-11-30
More Related Trials
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient
NCT01085474 ·Status: COMPLETED
-
Prospective Study of the Feedback From an Adherence Monitor on Asthma Control
NCT01529697 ·Status: COMPLETED ·Phase: NA
-
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
NCT02624505 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
ICS/LABA Combination With Integrated Dose Counter and Smartphone APP to Improve Asthma Control
NCT02556073 ·Status: UNKNOWN ·Phase: NA
-
Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications
NCT04185129 ·Status: UNKNOWN ·Phase: PHASE4
-
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
NCT01360021 ·Status: COMPLETED ·Phase: PHASE3
-
Asthmatuner a Self-management App for Asthma: A Randomized Controlled Multicentre Trial
NCT02571309 ·Status: COMPLETED ·Phase: NA
-
Inhaler Adherence in Severe Unstable Asthma
NCT02307669 ·Status: UNKNOWN ·Phase: NA
-
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
NCT02584257 ·Status: COMPLETED ·Phase: PHASE3
-
Automated Device for Asthma Monitoring
NCT01696357 ·Status: COMPLETED
-
Influence of Inhaler Compliance on the Treatment of Asthma Patients
NCT06108908 ·Status: RECRUITING
-
A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma
NCT06644924 ·Status: COMPLETED ·Phase: PHASE2
-
Real-world Effectiveness of Combination Therapy in Asthma
NCT01141465 ·Status: COMPLETED
-
Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma
NCT04912596 ·Status: RECRUITING ·Phase: NA
-
Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)
NCT00861926 ·Status: COMPLETED ·Phase: PHASE3
-
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
NCT00096616 ·Status: COMPLETED ·Phase: PHASE2
-
Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler
NCT00658255 ·Status: COMPLETED ·Phase: PHASE2
-
DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults
NCT00252863 ·Status: COMPLETED ·Phase: PHASE3
-
Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)
NCT00306163 ·Status: COMPLETED ·Phase: PHASE3
-
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
NCT00331292 ·Status: TERMINATED
-
Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy
NCT06568445 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
NCT00652392 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a 12-month Pharmaceutical Care Program on Control of Severe Asthma
NCT01644357 ·Status: COMPLETED ·Phase: NA